RFS
REGN icon

Rockefeller Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Rockefeller Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$49.7M Buy
132,164
+8,752
+7% +$3.54M 0.78% 38
2017
Q3 		$55.2M Sell
123,412
-95
-0.1% -$45.2K 1.05% 31
2017
Q2 		$60.7M Sell
123,507
-44,113
-26% -$19.3M 1.2% 30
2017
Q1 		$65M Buy
167,620
+19,275
+13% +$7.14M 1.3% 28
2016
Q4 		$54.5M Buy
148,345
+60,470
+69% +$23M 1.11% 32
2016
Q3 		$35.3M Sell
87,875
-4,095
-4% -$1.64M 0.74% 43
2016
Q2 		$32.1M Sell
91,970
-46,185
-33% -$17.8M 0.64% 43
2016
Q1 		$49.8M Buy
138,155
+31,946
+30% +$13.2M 0.97% 39
2015
Q4 		$57.7M Sell
106,209
-49,248
-32% -$26.7M 1.12% 35
2015
Q3 		$72.3M Buy
155,457
+10,528
+7% +$5.65M 1.47% 25
2015
Q2 		$73.9M Buy
144,929
+57,317
+65% +$28M 1.53% 25
2015
Q1 		$39.6M Buy
87,612
+2,974
+4% +$1.26M 0.85% 35
2014
Q4 		$34.7M Sell
84,638
-3,174
-4% -$1.25M 0.76% 40
2014
Q3 		$31.7M Sell
87,812
-22,568
-20% -$7.56M 0.71% 44
2014
Q2 		$31.2M Sell
110,380
-47,282
-30% -$14M 0.7% 46
2014
Q1 		$47.3M Buy
157,662
+129
+0.1% +$39.7K 1.03% 36
2013
Q4 		$43.4M Sell
157,533
-86,314
-35% -$24.8M 0.94% 38
2013
Q3 		$76.3M Sell
243,847
-23,532
-9% -$6.19M 1.77% 8
2013
Q2 		$60.1M Buy
+267,379
New +$62.3M 1.44% 17

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Rockefeller Financial Services's REGN Position: Q4 2017 in Review

Rockefeller Financial Services increased its Regeneron Pharmaceuticals (REGN) stake by 7.1% in Q4 2017, buying an estimated $3.54M and bringing the position to 132,164 shares worth $49.7M. The position accounts for 0.78% of the portfolio, ranked #38.

Rockefeller Financial Services first reported a position in REGN in Q2 2013 and has held it in 19 quarters since. The position peaked at $76.3M in Q3 2013. 638 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

  • Rockefeller Financial Services held 132,164 shares of Regeneron Pharmaceuticals worth $49.7M as of Q4 2017.
  • Rockefeller Financial Services bought 8,752 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $3.54M.
  • Regeneron Pharmaceuticals made up 0.78% of Rockefeller Financial Services's portfolio in Q4 2017, its #38 holding.
  • Rockefeller Financial Services first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 19 quarters since.
  • Rockefeller Financial Services's Regeneron Pharmaceuticals position peaked at $76.3M in Q3 2013.
  • 638 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.